1. Home
  2. BCAB vs SIF Comparison

BCAB vs SIF Comparison

Compare BCAB & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • SIF
  • Stock Information
  • Founded
  • BCAB 2007
  • SIF 1913
  • Country
  • BCAB United States
  • SIF United States
  • Employees
  • BCAB N/A
  • SIF N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • SIF Office Equipment/Supplies/Services
  • Sector
  • BCAB Health Care
  • SIF Industrials
  • Exchange
  • BCAB Nasdaq
  • SIF Nasdaq
  • Market Cap
  • BCAB 27.0M
  • SIF 22.6M
  • IPO Year
  • BCAB 2020
  • SIF N/A
  • Fundamental
  • Price
  • BCAB $0.31
  • SIF $2.91
  • Analyst Decision
  • BCAB Buy
  • SIF
  • Analyst Count
  • BCAB 2
  • SIF 0
  • Target Price
  • BCAB $5.00
  • SIF N/A
  • AVG Volume (30 Days)
  • BCAB 1.1M
  • SIF 4.2K
  • Earning Date
  • BCAB 03-25-2025
  • SIF 02-14-2025
  • Dividend Yield
  • BCAB N/A
  • SIF N/A
  • EPS Growth
  • BCAB N/A
  • SIF N/A
  • EPS
  • BCAB N/A
  • SIF N/A
  • Revenue
  • BCAB $11,000,000.00
  • SIF $85,042,000.00
  • Revenue This Year
  • BCAB N/A
  • SIF N/A
  • Revenue Next Year
  • BCAB N/A
  • SIF N/A
  • P/E Ratio
  • BCAB N/A
  • SIF N/A
  • Revenue Growth
  • BCAB N/A
  • SIF 41.17
  • 52 Week Low
  • BCAB $0.24
  • SIF $2.84
  • 52 Week High
  • BCAB $4.02
  • SIF $5.96
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 32.63
  • SIF 27.87
  • Support Level
  • BCAB $0.24
  • SIF $3.12
  • Resistance Level
  • BCAB $0.36
  • SIF $3.22
  • Average True Range (ATR)
  • BCAB 0.04
  • SIF 0.11
  • MACD
  • BCAB 0.01
  • SIF -0.03
  • Stochastic Oscillator
  • BCAB 29.39
  • SIF 11.32

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About SIF SIFCO Industries Inc.

SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.

Share on Social Networks: